Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand
Case Reports in Neurological Medicine 2017 DOI: 10.1155/2017/2503762 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 18-year-old Caucasian female from Australasia with persistently dilated pupils and history of psychedelic use |
| Keywords | Depression economics Pupillary response Pupillary light reflex Ajmaline Ophthalmology Anesthesia Pediatrics Audiology |
| Citations | 18 |
| Key findings | Persistent bilateral mydriasis with intact light reflex occurred in a young woman with psychedelic drug use and no detectable organic cause. |
Abstract
An eighteen-year-old female patient of the Caucasian ethnicity from Australasia presented with a persistently dilated pupil causing her discomfort and occasional burning sensation when she is outdoors due to oversensitivity to sunlight. However, her pupillary reaction to light (pupillary light reflex) was intact. The patient is a known user of psychedelic substances (entheogens) including LSD, NBOMe, psilocybin, and DMT. The condition affects both eyes to the same extent. Thorough medical, neurological, and radiological examinations, including an EEG and an MRI of the head and neck region, were completely normal. All these tests failed to detect any pathophysiological or anatomical abnormalities. The patient is a known case of chronic endogenous depression in association with attention deficit hyperactivity disorder, for which she is taking citalopram and Ritalin, respectively. There was neither a family history nor a similar congenital condition in her family.
Citations in the library
Cited by 8
- Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex Journal of Neurophysiology May 29, 2024
- Retrospective Analyses of High-risk NPS: Integrative Analyses of PubMed, Drug Fora, and the Surface Web Global Journal of Health Science September 18, 2017
- One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip Modern Applied Science February 13, 2019
- Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare Trends in Medical Research June 28, 2024
- Knowledge and (Ab)Use in Connection with Novel Psychoactive Substances: A Cross-Sectional Analysis of Psychedelic Users Existing on Online Platforms Global Journal of Health Science September 18, 2017
and 3 more in the library
Cites 6
- Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling Swiss Medical Weekly January 11, 2015
- Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine Human Psychopharmacology: Clinical and Experimental March 1, 2012
- Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. Journal of Neural Transmission September 12, 2009
- Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology October 1, 2014
- Neuroimaging in moderate MDMA use: A systematic review Neuroscience & Biobehavioral Reviews December 30, 2015
and 1 more in the library